UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report
(Date of earliest event reported): July 25, 2016 (July 25, 2016)
Phibro
Animal Health Corporation
(EXACT NAME
OF REGISTRANT AS SPECIFIED IN CHARTER)
| Delaware |
|
01-36410 |
|
13-1840497 |
(State
or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21
Teaneck, New Jersey 07666-6712
(Address
of Principal Executive Offices, including Zip Code)
(201) 329-7300
(Registrant’s telephone number,
including area code)
Not Applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below if this
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 OTHER EVENTS
On July 25, 2016, Phibro Animal Health Corporation
issued a press release announcing the declaration of a quarterly cash dividend of $0.10 per share on its Class A common stock and
Class B common stock, payable on September 28, 2016, to stockholders of record at the close of business on September 7, 2016. A
copy of the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated
herein by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit
Number |
|
Description |
| 99.1 |
|
Press Release, dated July 25, 2016. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
| |
PHIBRO ANIMAL HEALTH CORPORATION
Registrant |
| |
|
|
| Date: July 25, 2016 |
|
|
| |
|
|
| |
By: |
/s/ Thomas G. Dagger |
| |
Name: |
Thomas G. Dagger |
| |
Title: |
Senior Vice President, General Counsel |
| |
|
and Corporate Secretary |
